Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje
Iingcaphuno zeStock zeenkampani ezingama-71229 ngexesha langempela.
Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje

Iingcaphuno zempahla

Imali icatshulwa kwi-intanethi

Imbali icatshulwa ngemali

Imali yerhwebo yemali

Izabelo zeStock

Inzuzo kwizabelo zenkampani

Iingxelo zemali

Izabelo zezabelo zeenkampani. Kuphi utyalo mali?

Hyundai Pharmaceutical Co., Ltd. imbali icatshulwa imbali

Ixabiso lentengoHyundai Pharmaceutical Co., Ltd. e Laphumelela yaseMzantsi Korea ishati ukususela ekuqaleni kokuthengisa. Hyundai Pharmaceutical Co., Ltd. ixabiso lembali e Won ukususela ngoku 2000.
Yongeza kumajethijethi
Ukongezwa kumajethi

Hyundai Pharmaceutical Co., Ltd. zitshintshi e Laphumelela yaseMzantsi Korea imbali yamanani, ishati ukususela ekuqaleni kokuthengisa

Iindleko zezabelo Hyundai Pharmaceutical Co., Ltd. zatshintshile zibe ngu-+4.17% ngeveki. Ngenyanga edlulileyo, intengo yesabelo se-Hyundai Pharmaceutical Co., Ltd. yatshintsha ngo-+5.12%. Ukutshintsha kwintengo yesabelo se-004310.KS kwikota yokugqibela bekuyi-+9.17%. Ngonyaka kunye neminyaka emithathu, ixabiso lezabelo ze-Hyundai Pharmaceutical Co., Ltd. zatshintshela ku-+2.14% nakwi-+13.91%, ngokulandelana.

Bonisa:
Ukuze

Hyundai Pharmaceutical Co., Ltd. Won ixabiso lembali

 
Umhla Izinga
2023 Ku 4 530 Ukuze 5 340 KRW
2022 Ku 3 830 Ukuze 7 110 KRW
2021 Ku 4 930 Ukuze 9 920 KRW
2020 Ku 2 855 Ukuze 8 740 KRW
2019 Ku 3 815 Ukuze 5 550 KRW
2018 Ku 4 055 Ukuze 6 770 KRW
2017 Ku 3 370 Ukuze 4 597.840 KRW
2016 Ku 4 198.450 Ukuze 5 825.230 KRW
2015 Ku 2 615.510 Ukuze 4 909.560 KRW
2014 Ku 1 880.050 Ukuze 2 571.670 KRW
2013 Ku 1 597.550 Ukuze 1 938.500 KRW
2012 Ku 1 280.970 Ukuze 1 704.710 KRW
2011 Ku 1 159.200 Ukuze 1 573.200 KRW
2010 Ku 1 509.880 Ukuze 2 040.780 KRW
2009 Ku 2 133.320 Ukuze 2 951.580 KRW
2008 Ku 2 035.910 Ukuze 4 510.170 KRW
2007 Ku 2 289.180 Ukuze 4 773.180 KRW
2006 Ku 2 074.870 Ukuze 2 454.780 KRW
2005 Ku 2 026.170 Ukuze 2 513.230 KRW
2000 Ku 854.3 Ukuze 1 996.940 KRW

Iindleko zezabelo Hyundai Pharmaceutical Co., Ltd.

YezeMali Hyundai Pharmaceutical Co., Ltd.